Novartis  >>  Phase 3
Welcome,         Profile    Billing    Logout  

12»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 0102030405060708090100
            
            
             
buparlisib (AN2025) / Novartis, Adlai Nortye, Nippon Kayaku           
          
            
             
patupilone (EPO 906) / Novartis           
          
            
             
spartalizumab (PDR001) / Novartis           
          
            
             
Rydapt (midostaurin) / Novartis           
          
            
             
dovitinib (TKI258) / Novartis, Oncoheroes           
          
            
             
Kymriah (tisagenlecleucel-T) / Novartis           
          
            
             
vatalanib (PTK787) / Novartis, Bayer           
          
            
             
ianalumab (VAY736) / MorphoSys, Novartis           
          
            
             
Fabhalta (iptacopan) / Novartis           
          
            
             
dactolisib (RTB101) / Adicet Bio           
          
            
             
gevokizumab (VPM087) / Novartis           
          
            
             
Truseltiq (infigratinib) / BridgeBio, Pfizer, Xediton Pharma           
          
            
             
mavoglurant (STP7) / STALICLA           
          
            
             
nelarabine / Generic mfg.           
          
            
             
remibrutinib (LOU064) / Novartis           
          
            
             
figitumumab (CP-751,871) / Novartis           
          
            
             
Xinlay (atrasentan) / Novartis           
          
            
             
ligelizumab (QGE031) / Novartis           
          
            
             
fevipiprant (QAW039) / Novartis           
          
            
             
sabatolimab (MBG453) / Novartis           
          
            
             
Atectura Breezhaler (indacaterol/mometasone furoate) / Novartis, Merck (MSD)           
          
            
             
Reasanz (serelaxin) / Novartis           
          
            
             
ociperlimab (BGB-A1217) / BeiGene           
          
            
             
pelacarsen (AKCEA-APO(a)-LRx) / Ionis, Novartis           
          
            
             
bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly           
          
            
             
olezarsen (AKCEA-APOCIII-LRx) / Ionis           
          
            
             
pradigastat (LCQ908) / Novartis           
          
            
             
Enerzair Breezhaler (glycopyrrolate/indacaterol/mometasone) / Novartis           
          
            
             
Waylivra (volanesorsen) / Novartis, SOBI           
          
            
             
nisevokitug (NIS793) / Novartis           
          
            
             
Vynfinit (vintafolide) / Novartis           
          
            
             
nazartinib (EGF816) / Novartis           
          
            
             
opnurasib (JDQ443) / Novartis           
          
            
             
abelacimab (MAA868) / Anthos Therap, Novartis, MorphoSys, Lonza           
          
            
             
setrusumab (BPS804) / Mereo Biopharma, Ultragenyx           
          
            
             
Miostat (carbachol) / Novartis           
          
            
             
teprasiran (QPI-1002) / Novartis, SBI Biotech           
          
            
             
GVAX lung cancer vaccine / Dana-Farber Cancer Institute, Novartis           
          
            
             
Joenja (leniolisib) / Pharming Group           
          
            
             
MAS825 / Novartis           
          
            
             
Oclaiz (octreotide subcutaneous depot) / Camurus           
          
            
             
amilomotide (CAD106) / Novartis           
          
            
             
naporafenib (ERAS-254) / Erasca           
          
            
             
Zolgensma Intrathecal (onasemnogene abeparvovec-xioi intrathecal) / Novartis           
          
            
             
Ixifi (infliximab-qbtx) / Pfizer, Sandoz           
          
            
             
Rixathon (rituximab biosimilar) / Kyowa Kirin, Sandoz           
          
            
             
brinzolamide/travoprost / Novartis           
          
            
             
darovasertib (IDE196) / Ideaya Biosci           
          
            
             
ensovibep (MP0420) / AGC Biologics, Molecular Partners, Novartis           
          
            
             
zigakibart (BION-1301) / Novartis           
          
            
            


12»